Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Juno Pharmaceuticals Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (266)
Cancellation by sponsor (71)
Prescription medicine registration (27)
Section 14, TGO91 consent (6)
Australian Public Assessment Report (AusPAR) (1)
Prescription medicine decision summary (1)

Date

2025 (10)
2024 (13)
2023 (18)
2022 (36)
2021 (70)
2020 (45)
2019 (51)
2018 (18)
2017 (14)
2016 (14)
2015 (14)
2014 (7)
2013 (8)
2012 (12)
2011 (3)
2010 (1)
2009 (2)
2007 (1)
2006 (4)
2003 (7)
2000 (1)
1999 (5)
1998 (1)
1996 (3)
1994 (3)
1991 (11)

Search

Sponsor content

372 result(s) found, displaying 261 to 270

VALGANCICLOVIR AMNEAL valganciclovir (as hydrochloride) 450 mg film coated tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
VALGANCICLOVIR KP valganciclovir (as hydrochloride) 450 mg film coated tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
LANTIM 50/5 latanoprost 50 microgram/mL and timolol 5 mg/mL (as maleate) eye drops solution bottle Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
GLIVANIB imatinib (as mesilate) 100 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
GLIVANIB imatinib (as mesilate) 400 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
ANASTROZOLE AN anastrozole 1 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
CASPOFUNGIN AN caspofungin (as acetate) 70 mg powder for injection vial (276642)

22 December 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CASPOFUNGIN AN caspofungin (as acetate) 70 mg powder for injection vial.
CASPOFUNGIN AN caspofungin (as acetate) 50 mg powder for injection vial (269932)

22 December 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CASPOFUNGIN AN caspofungin (as acetate) 50 mg powder for injection vial.
VALGANCICLOVIR CW valganciclovir (as hydrochloride) 450 mg film coated tablet bottle (262933)

20 September 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VALGANCICLOVIR CW valganciclovir (as hydrochloride) 450 mg film coated tablet bottle.
ZOLFEND voriconazole 200 mg powder for injection vial (238265)

22 July 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ZOLFEND voriconazole 200 mg powder for injection vial.

Pages

First page
Previous page
…
Page 23
Page 24
Page 25
Page 26
Current page 27
Page 28
Page 29
Page 30
Page 31
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.